BURLINGTON -
The addition of Toxikon to Labcorp Drug Development bolsters
The definitive agreement for the transaction was announced on
About
Contact:
Tel: 336-436-8263
Email: Media@Labcorp.com
(C) 2021 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
201.3 USD | +0.53% | +1.47% | -11.43% |
BURLINGTON -
The addition of Toxikon to Labcorp Drug Development bolsters
The definitive agreement for the transaction was announced on
About
Contact:
Tel: 336-436-8263
Email: Media@Labcorp.com
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-11.43% | 16.97B | |
+13.70% | 81.4B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
+28.34% | 11.79B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |